214 related articles for article (PubMed ID: 15563668)
1. Design of a real time quantitative PCR assay to assess global mRNA amplification of small size specimens for microarray hybridisation.
Choesmel V; Foucault F; Thiery JP; Blin N
J Clin Pathol; 2004 Dec; 57(12):1278-87. PubMed ID: 15563668
[TBL] [Abstract][Full Text] [Related]
2. An alternative method to amplify RNA without loss of signal conservation for expression analysis with a proteinase DNA microarray in the ArrayTube format.
Schüler S; Wenz I; Wiederanders B; Slickers P; Ehricht R
BMC Genomics; 2006 Jun; 7():144. PubMed ID: 16768788
[TBL] [Abstract][Full Text] [Related]
3. [Use of the real-time RT-PCR method for investigation of small stable RNA expression level in human epidermoid carcinoma cells A431].
Nikitina TV; Nazarova NIu; Tishchenko LI; Tuohimaa P; Sedova VM
Tsitologiia; 2003; 45(4):392-402. PubMed ID: 14520871
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of a 3' end tag PCR and a linear RNA amplification approach for microarray analysis.
Laurell C; Wirta V; Nilsson P; Lundeberg J
J Biotechnol; 2007 Jan; 127(4):638-46. PubMed ID: 16997411
[TBL] [Abstract][Full Text] [Related]
5. Microarray analysis in clinical oncology: pre-clinical optimization using needle core biopsies from xenograft tumors.
Goley EM; Anderson SJ; Ménard C; Chuang E; Lü X; Tofilon PJ; Camphausen K
BMC Cancer; 2004 May; 4():20. PubMed ID: 15151703
[TBL] [Abstract][Full Text] [Related]
6. Real-time quantitative PCR determination of urokinase-type plasminogen activator receptor (uPAR) expression of isolated micrometastatic cells from bone marrow of breast cancer patients.
Pierga JY; Bonneton C; Magdelénat H; Vincent-Salomon A; Nos C; Boudou E; Pouillart P; Thiery JP; de Cremoux P
Int J Cancer; 2005 Mar; 114(2):291-8. PubMed ID: 15543615
[TBL] [Abstract][Full Text] [Related]
7. Validity of messenger RNA expression analyses of human saliva.
Kumar SV; Hurteau GJ; Spivack SD
Clin Cancer Res; 2006 Sep; 12(17):5033-9. PubMed ID: 16951218
[TBL] [Abstract][Full Text] [Related]
8. Validation of cDNA microarray gene expression data obtained from linearly amplified RNA.
Jenson SD; Robetorye RS; Bohling SD; Schumacher JA; Morgan JW; Lim MS; Elenitoba-Johnson KS
Mol Pathol; 2003 Dec; 56(6):307-12. PubMed ID: 14645691
[TBL] [Abstract][Full Text] [Related]
9. Ultrasensitive DNA chip: gene expression profile analysis without RNA amplification.
Nagino K; Nomura O; Takii Y; Myomoto A; Ichikawa M; Nakamura F; Higasa M; Akiyama H; Nobumasa H; Shiojima S; Tsujimoto G
J Biochem; 2006 Apr; 139(4):697-703. PubMed ID: 16672270
[TBL] [Abstract][Full Text] [Related]
10. Advantages of mRNA amplification for microarray analysis.
Feldman AL; Costouros NG; Wang E; Qian M; Marincola FM; Alexander HR; Libutti SK
Biotechniques; 2002 Oct; 33(4):906-12, 914. PubMed ID: 12398200
[TBL] [Abstract][Full Text] [Related]
11. Systematic analysis of T7 RNA polymerase based in vitro linear RNA amplification for use in microarray experiments.
Schneider J; Buness A; Huber W; Volz J; Kioschis P; Hafner M; Poustka A; Sültmann H
BMC Genomics; 2004 Apr; 5(1):29. PubMed ID: 15119961
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer.
Urban P; Vuaroqueaux V; Labuhn M; Delorenzi M; Wirapati P; Wight E; Senn HJ; Benz C; Eppenberger U; Eppenberger-Castori S
J Clin Oncol; 2006 Sep; 24(26):4245-53. PubMed ID: 16963728
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator system in osteoclasts.
Yang JN; Allan EH; Anderson GI; Martin TJ; Minkin C
J Bone Miner Res; 1997 May; 12(5):761-8. PubMed ID: 9144342
[TBL] [Abstract][Full Text] [Related]
14. Design and evaluation of Actichip, a thematic microarray for the study of the actin cytoskeleton.
Muller J; Mehlen A; Vetter G; Yatskou M; Muller A; Chalmel F; Poch O; Friederich E; Vallar L
BMC Genomics; 2007 Aug; 8():294. PubMed ID: 17727702
[TBL] [Abstract][Full Text] [Related]
15. Validation and application of a high fidelity mRNA linear amplification procedure for profiling gene expression.
Patel OV; Suchyta SP; Sipkovsky SS; Yao J; Ireland JJ; Coussens PM; Smith GW
Vet Immunol Immunopathol; 2005 May; 105(3-4):331-42. PubMed ID: 15808310
[TBL] [Abstract][Full Text] [Related]
16. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
[TBL] [Abstract][Full Text] [Related]
17. Expression and localization of the urokinase-type plasminogen activator receptor (uPAR) in the human placenta.
Nishida Y; Hayashi Y; Imai Y; Itoh H
Kobe J Med Sci; 1998 Feb; 44(1):31-43. PubMed ID: 9846056
[TBL] [Abstract][Full Text] [Related]
18. Current issues for DNA microarrays: platform comparison, double linear amplification, and universal RNA reference.
Park PJ; Cao YA; Lee SY; Kim JW; Chang MS; Hart R; Choi S
J Biotechnol; 2004 Sep; 112(3):225-45. PubMed ID: 15313001
[TBL] [Abstract][Full Text] [Related]
19. Detection of mRNAs for urokinase-type plasminogen activator, its receptor, and type 1 inhibitor in giant cell tumors of bone with in situ hybridization.
Zheng MH; Fan Y; Panicker A; Smith A; Robertson T; Wysocki S; Robbins P; Papadimitriou JM; Wood DJ
Am J Pathol; 1995 Dec; 147(6):1559-66. PubMed ID: 7495280
[TBL] [Abstract][Full Text] [Related]
20. A highly sensitive and specific system for large-scale gene expression profiling.
Hu G; Yang Q; Cui X; Yue G; Azaro MA; Wang HY; Li H
BMC Genomics; 2008 Jan; 9():9. PubMed ID: 18186939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
